Placebo-Controlled Phase 3 Trial of a Recombinant Glycoprotein 120 Vaccine to Prevent HIV-1 Infection.
Journal of Infectious Diseases, 2005, vol. 191, issue 5, p 654, ISSN 00221899. ISBN 00221899.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via Electronic Journal Services